Other OTC Pharmaceuticals - Mauritius

  • Mauritius
  • The Other OTC Pharmaceuticals market in Mauritius generated a revenue of US$15.49 in 2024.
  • It is projected to experience an annual growth rate of 1.53% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States leads with a revenue of US$7,171.00 in 2024.
  • Looking at the population figures, in Mauritius generated a per person revenue of US$11.90 in 2024.
  • Mauritius is experiencing a growing demand for Other OTC Pharmaceuticals, driven by an increasing focus on self-care and preventative healthcare.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Mauritius is experiencing steady growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory.Customer preferences in Mauritius play a significant role in the development of the Other OTC Pharmaceuticals market. Consumers in the country are increasingly seeking self-care options and are becoming more health-conscious. They are looking for accessible and affordable healthcare solutions that do not require a doctor's prescription. This preference for over-the-counter medications is driving the demand for Other OTC Pharmaceuticals in the market.Trends in the market also contribute to the growth of the Other OTC Pharmaceuticals market in Mauritius. One notable trend is the increasing availability and variety of over-the-counter medications in pharmacies and retail outlets. This trend is driven by the growing number of pharmaceutical companies and distributors entering the market, as well as the expansion of existing players. The increased competition leads to a wider range of products being offered to consumers, catering to their specific needs and preferences.Another trend in the market is the rising popularity of natural and herbal remedies. Consumers in Mauritius are increasingly looking for alternative healthcare options that are perceived to be safer and have fewer side effects. This trend is driving the demand for natural and herbal over-the-counter medications, leading to the development of new products in this category.Local special circumstances also contribute to the growth of the Other OTC Pharmaceuticals market in Mauritius. The country has a well-established healthcare system with a network of pharmacies and healthcare professionals. This infrastructure facilitates the distribution and accessibility of over-the-counter medications to consumers. Additionally, the government of Mauritius has implemented policies and regulations that support the development and availability of over-the-counter medications, further driving the market growth.Underlying macroeconomic factors also play a role in the development of the Other OTC Pharmaceuticals market in Mauritius. The country has a stable and growing economy, which contributes to increased consumer spending power. As disposable incomes rise, consumers are more willing to invest in their health and well-being, leading to increased demand for over-the-counter medications.In conclusion, the Other OTC Pharmaceuticals market in Mauritius is developing due to customer preferences for self-care options, trends in the market such as the availability of a wider range of products and the popularity of natural remedies, local special circumstances including a well-established healthcare system, and underlying macroeconomic factors such as a stable economy and increased consumer spending power. This positive trajectory is expected to continue as the market continues to evolve and meet the changing needs of consumers in Mauritius.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)